Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down1.35% Nasdaq Down1.12%

West Pharmaceutical Services, Inc. (WST)

-NYSE

67.51 Down 0.66(0.97%) 3:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 339,400   321,500   303,800   324,800  
Cost of Revenue227,700  224,000  213,400  226,100  
Gross Profit 111,700   97,500   90,400   98,700  
Operating Expenses
Research Development9,100  8,600  8,100  8,200  
Selling General and Administrative59,100  58,600  53,800  54,400  
Non Recurring200  (1,200)2,200  500  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 43,300   31,500   26,300   35,600  
Income from Continuing Operations
Total Other Income/Expenses Net400  300  500  (11,000)
Earnings Before Interest And Taxes43,700  31,800  26,800  24,600  
Interest Expense4,600  3,500  4,400  4,500  
Income Before Tax39,100  28,300  22,400  20,100  
Income Tax Expense8,600  7,200  9,100  6,600  
Minority Interest -   -   -   -  
Net Income From Continuing Ops31,500  21,100  14,800  4,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 31,700   21,100   14,800   15,600  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 31,700   21,100   14,800   15,600  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.